Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna Price to Book Value : 4.638 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.638 |
| November 11, 2026 | 5.38 |
| November 10, 2026 | 5.799 |
| November 09, 2026 | 5.622 |
| November 06, 2026 | 5.412 |
| November 05, 2026 | 5.246 |
| November 04, 2026 | 5.305 |
| November 03, 2026 | 4.842 |
| November 02, 2026 | 4.786 |
| October 30, 2026 | 4.875 |
| October 29, 2026 | 5.011 |
| October 28, 2026 | 4.902 |
| October 27, 2026 | 4.890 |
| October 26, 2026 | 4.584 |
| October 23, 2026 | 4.477 |
| October 22, 2026 | 4.529 |
| October 21, 2026 | 4.516 |
| October 20, 2026 | 4.360 |
| October 19, 2026 | 4.031 |
| October 16, 2026 | 4.027 |
| October 15, 2026 | 4.149 |
| October 14, 2026 | 4.024 |
| October 13, 2026 | 4.034 |
| October 12, 2026 | 4.161 |
| October 09, 2026 | 4.251 |
| Date | Value |
|---|---|
| October 08, 2026 | 4.088 |
| October 07, 2026 | 3.988 |
| October 06, 2026 | 3.952 |
| October 05, 2026 | 4.196 |
| October 02, 2026 | 4.178 |
| October 01, 2026 | 4.216 |
| September 30, 2026 | 4.335 |
| September 29, 2026 | 4.621 |
| September 28, 2026 | 4.693 |
| September 25, 2026 | 4.460 |
| September 24, 2026 | 4.503 |
| September 23, 2026 | 4.540 |
| September 22, 2026 | 4.768 |
| September 21, 2026 | 4.551 |
| September 18, 2026 | 4.569 |
| September 17, 2026 | 4.664 |
| September 16, 2026 | 4.539 |
| September 15, 2026 | 4.589 |
| September 14, 2026 | 4.670 |
| September 11, 2026 | 4.548 |
| September 10, 2026 | 4.458 |
| September 09, 2026 | 4.484 |
| September 08, 2026 | 4.413 |
| September 04, 2026 | 4.340 |
| September 03, 2026 | 4.346 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.08 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8758 |
| Fulcrum Therapeutics, Inc. | 0.9035 |
| Definium Therapeutics, Inc. | 4.666 |
Price to Book Value Related Metrics
| PS Ratio | 19.71 |
| Price | 41.86 |
| Earnings Yield | -3.08% |
| Market Cap | 1.985B |